Diffuse noxious inhibitory control is delayed in chronic fatigue syndrome: An experimental study

Pain

Volumn 139, Issue 2, 2008, Pages 439-448

  Meeus, Mira ^a,b   Nijs, Jo ^a,b   Van de Wauwer, Naomi ^a   Toeback, Linda ^a   Truijen, Steven ^a  

^a Hogeschool Antwerpen   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Chronic fatigue syndrome (CFS); Cortisol; Diffuse noxious inhibitory controls (DNIC); HPA axis; Pain; Spatial summation

Indexed keywords

HOT WATER; HYDROCORTISONE;

ADULT; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSE NOXIOUS INHIBITORY CONTROL; FEMALE; HORMONE RESPONSE; HUMAN; HYPERALGESIA; MALE; NOCICEPTION; NOCICEPTIVE STIMULATION; PAIN; PRIORITY JOURNAL; SPATIAL SUMMATION; THERMAL STIMULATION; WATER IMMERSION;

ADULT; FATIGUE SYNDROME, CHRONIC; FEEDBACK; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; NEURAL INHIBITION; PAIN; PAIN THRESHOLD; SALIVA;

EID: 53049087260     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2008.05.018     Document Type: Article

References (37)

1. Aardal E., and Holm A.C. Cortisol in saliva - reference ranges and relation to cortisol in serum. Eur J Clin Chem Clin Biochem 33 (1995) 927-932
2. al'Absi M., Petersen K.L., and Wittmers L.E. Adrenocortical and hemodynamic predictors of pain perception in men and women. Pain 96 (2002) 197-204
3. Bennett G.J. Update on the neurophysiology of pain transmission and modulation: focus on the NMDA-receptor. J Pain Symptom Manage 19 (2000) S2-S6
4. Bouhassira D., Gall O., Chitour D., and Le Bars D. Dorsal horn convergent neurones: negative feedback triggered by spatial summation of nociceptive afferents. Pain 62 (1995) 195-200
5. Cleare A.J. The HPA axis and the genesis of chronic fatigue syndrome. Trends Endocrinol Metab 15 (2004) 55-59
6. Costa D.C., Tannock C., and Brostoff J. Brainstem perfusion is impaired in chronic fatigue syndrome. QJM 88 (1995) 767-773
7. Edwards S., Clow A., Evans P., and Hucklebridge F. Exploration of the awakening cortisol response in relation to diurnal cortisol secretory activity. Life Sci 68 (2001) 2093-2103
8. Evengard B., Nilsson C.G., Lindh G., Lindquist L., Eneroth P., Fredrikson S., et al. Chronic fatigue syndrome differs from fibromyalgia. No evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome. Pain 78 (1998) 153-155
9. France C.R., and Suchowiecki S. A comparison of diffuse noxious inhibitory controls in men and women. Pain 81 (1999) 77-84
10. Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., and Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Int Med 121 (1994) 953-959
11. Julien N., Goffaux P., Arsenault P., and Marchand S. Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 114 (2005) 295-302
12. Kirschbaum C., and Hellhammer D.H. Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology 19 (1994) 313-333
13. Kosek E., Ekholm J., and Hansson P. Modulation of pressure pain thresholds during and following isometric contraction in patients with fibromyalgia and in healthy controls. Pain 64 (1996) 415-423
14. Kosek E., and Hansson P. Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects. Pain 70 (1997) 41-51
15. Lautenbacher S., and Rollman G.B. Possible deficiencies of pain modulation in fibromyalgia. Clin J Pain 13 (1997) 189-196
16. Lautenbacher S., Roscher S., Kohl G., Vedder H., and Krieg J. Corticotropin-releasing-hormone lacks analgesic properties: an experimental study in humans, using non-inflammatory pain. Pain 83 (1999) 1-7
17. Lundberg U. Stress hormones in health and illness: the roles of work and gender. Psychoneuroendocrinology 30 (2005) 1017-1021
18. Marchand S., and Arsenault P. Spatial summation for pain perception: interaction of inhibitory and excitatory mechanisms. Pain 95 (2002) 201-206
19. Meeus M., and Nijs J. Central sensitization: a biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome. Clin Rheumatol 26 (2007) 465-473
20. Meeus M., Nijs J., and Meirleir K.D. Chronic musculoskeletal pain in patients with the chronic fatigue syndrome: a systematic review. Eur J Pain 11 (2007) 377-386
21. Miller D.B., and O'Callaghan J.P. Neuroendocrine aspects of the response to stress. Metabolism 51 (2002) 5-10
22. Motohashi K., and Umino M. Heterotopic painful stimulation decreases the late component of somatosensory evoked potentials induced by electrical tooth stimulation. Brain Res Cogn Brain Res 11 (2001) 39-46
23. Mountz J.M., Bradley L.A., Modell J.G., Alexander R.W., Triana-Alexander M., Aaron L.A., et al. Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 38 (1995) 926-938
24. Price D.D., McHaffie J.G., and Larson M.A. Spatial summation of heat-induced pain: influence of stimulus area and spatial separation of stimuli on perceived pain sensation intensity and unpleasantness. J Neurophysiol 62 (1989) 1270-1279
25. Russell I.J., Orr M.D., Littman B., Vipraio G.A., Alboukrek D., Michalek J.E., et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 37 (1994) 1593-1601
26. Staud R., Robinson M.E., and Price D.D. Isometric exercise has opposite effects on central pain mechanisms in fibromyalgia patients compared to normal controls. Pain 118 (2005) 176-184
27. Staud R., Vierck C.J., Robinson M.E., and Price D.D. Spatial summation of heat pain within and across dermatomes in fibromyalgia patients and pain-free subjects. Pain 111 (2004) 342-350
28. Tirelli U., Chierichetti F., Tavio M., Simonelli C., Bianchin G., and Zanco P. Brain positron emission tomography (PET) in chronic fatigue syndrome: preliminary data. Am J Med 105 (1998) 54S-58S
29. Van Den Eede F., Moorkens G., Van Houdenhove B., Cosyns P., and Claes S.J. Hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome. Neuropsychobiology 55 (2007) 112-120
30. Vierck Jr. C.J., Staud R., Price D.D., Cannon R.L., Mauderli A.P., and Martin A.D. The effect of maximal exercise on temporal summation of second pain (windup) in patients with fibromyalgia syndrome. J Pain 2 (2001) 334-344
31. Vining R.F., and McGinley R.A. The measurement of hormones in saliva: possibilities and pitfalls. J Steroid Biochem 27 (1987) 81-94
32. Vining R.F., McGinley R.A., Maksvytis J.J., and Ho K.Y. Salivary cortisol: a better measure of adrenal cortical function than serum cortisol. Ann Clin Biochem 20 Pt. 6 (1983) 329-335
33. Whiteside A., Hansen S., and Chaudhuri A. Exercise lowers pain threshold in chronic fatigue syndrome. Pain 109 (2004) 497-499
34. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 1990;33:160-72.
35. Wood B., Wessely S., Papadopoulos A., Poon L., and Checkley S. Salivary cortisol profiles in chronic fatigue syndrome. Neuropsychobiology 37 (1998) 1-4
36. Young A.H., Sharpe M., Clements A., Dowling B., Hawton K.E., and Cowen P.J. Basal activity of the hypothalamic-pituitary-adrenal axis in patients with the chronic fatigue syndrome (neurasthenia). Biol Psychiatry 43 (1998) 236-237
37. Zusman M. Forebrain-mediated sensitization of central pain pathways: 'non-specific' pain and a new image for MT. Man Ther 7 (2002) 80-88